Ataxia-Telangiectasia (A-T) is a rare, inherited neurological disorder that affects the brain, muscles, and immune system. The primary cause of A-T is a mutation in a gene called ATM (Ataxia-Telangiectasia Mutated) located on chromosome 11. This gene is responsible for the production of a protein called ATM protein, which is involved in several important cellular functions, such as DNA repair, cell cycle control, and regulation of the immune system.
People with A-T have a mutation in the ATM gene that results in a lack of functional ATM protein. This causes a variety of symptoms, including progressive deterioration of muscle coordination, difficulty walking, poor balance, slurred speech, an increased risk of infections, and an increased risk of cancer.
In addition to the mutation in the ATM gene, environmental factors, such as exposure to certain toxins, have been linked to A-T. For example, exposure to certain types of pesticides has been associated with an increased risk of A-T.
A-T is typically diagnosed in childhood and is usually progressive. Unfortunately, there is no cure for A-T, but there are treatments available that can help manage symptoms and slow the progression of the disorder. These treatments include physical therapy, occupational therapy, speech therapy, and medications to help manage infections and reduce the risk of cancer.